Previously, studies have shown BRCA1 IHC is effective method to screen for genetic BRCA1 alterations (12, 26), and BRCA1 IHC testing has been performed for ovarian cancer with excellent correlation with survival (12, 26–29). Here, BRCA1 is linked to ovarian carcinoma.